Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

Research Institute

MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Disease Types: Solid Tumors

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

For More Information:

https://clinicaltrials.gov/ct2/show/NCT03785249?term=A+Phase+1%2F2+Multiple+Expansion+Cohort+Trial+of+MRTX849+in+Patients+with+Advanced+Solid+Tumors+with+KRAS+G12C+Mutation&draw=2&rank=1